Wade Walke | Vice President-Investor Relations |
Brett Monia | Chief Executive Officer |
Onaiza Cadoret | Chief Corporate Development and Commercial Officer |
Beth Hougen | Chief Financial Officer |
Richard Geary | Senior Vice President-Development |
Eric Swayze | Senior Vice President-Research |
Jason Gerberry | Bank of America |
Jim Birchenough | Wells Fargo |
Esther Rajavelu | Openheimer |
Nate Tower | Stifel |
Chad Messer | Needham and Company |
Vincent Chen | Bernstein |
Eliana Merle | Cantor Fitzgerald |
Jessica Fye | J.P. Morgan |
Ross Weinreb | Goldman Sachs |
Yale Jen | Laidlaw and Company |
Gena Wang | Barclays |
Good day, and welcome to Ionis Pharmaceuticals Q4 and Full Year 2019 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Wade Walke, Vice President, Investor Relations.